Cargando…
Dendritic Cell Cancer Vaccines: From the Bench to the Bedside
The recognition that the development of cancer is associated with acquired immunodeficiency, mostly against cancer cells themselves, and understanding pathways inducing this immunosuppression, has led to a tremendous development of new immunological approaches, both vaccines and drugs, which overcom...
Autores principales: | Katz, Tamar, Avivi, Irit, Benyamini, Noam, Rosenblatt, Jacalyn, Avigan, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rambam Health Care Campus
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222413/ https://www.ncbi.nlm.nih.gov/pubmed/25386340 http://dx.doi.org/10.5041/RMMJ.10158 |
Ejemplares similares
-
Messenger RNA vaccines against SARS-CoV-2
por: Topol, Eric J.
Publicado: (2021) -
Impact of Heparanase and the Tumor Microenvironment on Cancer Metastasis and Angiogenesis: Basic Aspects and Clinical Applications
por: Vlodavsky, Israel, et al.
Publicado: (2011) -
Genetic Stratification in Myeloid Diseases: From Risk Assessment to Clinical Decision Support Tool
por: Ofran, Yishai
Publicado: (2014) -
ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies
por: Sarig, Galit
Publicado: (2014) -
Minimal Residual Disease Surveillance in Chronic Lymphocytic Leukemia by Fluorescence-Activated Cell Sorting
por: Ringelstein-Harlev, Shimrit, et al.
Publicado: (2014)